For appointments

Call the office

Folsom, California Office: 916-983-4444

Call Now

Close

WHO:

Dr. Gish is a Hepatologist specializing in all forms of liver disease, liver cancer and liver transplant. Dr. Gish has partnered with TeleMed2U to provide telemedicine consultative services for patients with liver disease.

WHAT:

TeleMed2U is a telemedicine-based multi-specialty clinical practice increasing access to specialist providers providing, “healthcare anywhere and everywhere.” The telemedicine consultation will be conducted through our HIPAA and HITECH compliant platform. Connectivity testing will be done in advance to ensure you can connect via our telemedicine platform. Following the consultation, a clinical note will be provided including a summary of your liver consultation with Dr. Gish and his consultative recommendations.

COST:

Payment will be processed through an online secure transaction portal. The fees for consultative services are:

Initial 60 minute consultation per patient: $500.00
Follow Up 30 minute consultation per patient: $300.00

NEXT STEPS:

If you’d like to continue, please click Next to complete the form and we will contact you to schedule connectivity testing. During the test you will have the opportunity to determine the method of providing medical records, discuss appointment availability as well as discuss any additional questions that you have. If you are a healthcare facility interested in services, please complete the form and we can discuss the options that are right for you and your patients.

Email

Subject

Country

You should be aware of the general risks of transmitting information over the Internet, which may not use encryption. You should therefore not share any personal medical information that you would wish to be held confidential in a physician/patient or similar clinical relationship.

The information contained on this website is not intended, should not substitute for, or be used instead of, a clinical or therapeutic relationship with a health care professional who is fully familiar with the specifics of your case. The information on this site may assist you in your personal, general research but none of it constitutes the practice of medicine or any other health care profession.

Nothing in this site is intended as a recommendation or endorsement of any specific tests, products, procedures, healthcare provider, opinions, or other information that may be mentioned in this site. Any reliance on any information provided by the website personnel, others appearing on the site at the invitation of the website and/or other visitors to the site is solely at the user's risk.

E-mail correspondence with Dr. Robert G. Gish Consultants, LLC or any of its employees, or agents, does not create a physician/patient relationship between us or cause Dr. Gish to create or retain any medical records about you, monitor your care, or communicate with your own health care provider.

Always seek the advice of your physician or other qualified health care provider with any questions you have regarding your medical care. If you suspect that you may have a medical condition, or are seeking medical advice or treatment, we recommend that you consult a qualified health professional as soon as possible.

Powered by

Close Form

World Hepatitis Day 2017 - CEVHAP Activity Update

Jul 28, 2017 • CEVHAP

Dear CEVHAP members and friends,

As we all prepare to mark World Hepatitis Day today, I want to update you on the two key initiatives we’ve been working on in recent months. Given that so many of our members are now autonomously running their own WHD campaigns and activities locally, which is terrific, we took the decision to invest in an initiative that aimed to “expand” the reach of World Hepatitis Day beyond the one official day on 28 July by generating media interest in hepatitis ahead of the actual day.

We have also spent some time considering the shift in policy focus from global/regional advocacy to national level policy and programme implementation to identify strategies that CEVHAP can use to best respond to these changes in ways that can add value for those who are most affected by hepatitis.

1. Viral Hepatitis Policy in Asia Survey 2016

As you are aware, the report Viral Hepatitis Policy in Asia Survey 2016 conducted for CEVHAP by the Chinese University of Hong Kong (CUHK) Centre for Global Health, was launched a few weeks ahead of World Hepatitis Day, on 14 June, at a Press Conference in Hong Kong which was presided over by CUHK Vice-Chancellor and CEVHAP Founding member, Prof Joseph Sung and lead author, Prof Tammy Meyers of the Centre for Global Health. The data and information from the survey presented at the event continues to generate interest and appears to have provided some impetus for several journalists in the region to give greater attention to hepatitis and World Hepatitis Day. Attached is the report previously distributed and summary of the media coverage it has received.

2. CEVHAP Strategy 2017-2021

Following an executive workshop in early May, we have developed a strategic framework for CEVHAP through to 2021. In response to the many developments and achievements in hepatitis policy and advocacy since the inception of CEVHAP in 2010, our current strategy takes our focus from what has been a global/regional perspective, to one that seeks to strengthen the support we provide at a local level with emphasis on two key areas: 1) raising awareness of the social and economic impacts of viral hepatitis; 2) advocating for quality standards for health practitioners and national health systems supporting people affected by hepatitis.

Our next steps are to develop actions to support the four objectives outlined and we would welcome your suggestions for local pilot programs, projects and activities that would work towards these objectives. You will find attached a paper setting out the strategy, along with an infographic which more simply conveys our strategy “in a nutshell”.

I wish you all the best for your activities to mark this World Hepatitis Day 2017!

Best wishes,

Jenny

Jennifer Johnston

Executive Director, CEVHAP

Metadata